Delivery Order SPE2DB22D1002-SPE2DB25FLEV0
- Not listed
- The Defense Logistics Agency awarded a $1,384.20 firm fixed-price delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of Tresiba FlexTouch 100 Unit/ML 3ML insulin pens. This is a non-set-aside contract with an ultimate completion date of August 13, 2025, and performance will occur at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop...
- The Defense Logistics Agency awarded a $2,076.30 delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Tresiba FlexTouch 100 Unit/mL 3mL insulin pens, with an ultimate completion date of August 19, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and is being performed at the contractor's facility in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC)...
- The Defense Logistics Agency awarded a delivery order valued at $2,491.38 to AmerisourceBergen Drug Corp for the supply of Tresiba FlexTouch 200 Unit/ML insulin pens (3 ML). This competitively awarded, firm fixed-price delivery order was issued on September 8, 2025, with an ultimate completion date of September 9, 2025. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 31, 2025, for the supply of Tresiba FlexTouch 100 unit/mL insulin pens in 3mL quantities. This $2,146.80 firm fixed-price delivery order, with an ultimate completion date of August 1, 2025, represents a non-set-aside competitive award supporting federal medical procurement needs. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency awarded a $4,222.74 delivery order to AmerisourceBergen Drug Corp for Tresiba FlexTouch 200 unit/ml insulin pens (3ml). This contract, awarded on July 21, 2025, represents a firm fixed-price procurement with an ultimate completion date of July 22, 2025. The award was not set-aside and was competitively awarded through open competition. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor and will perform the work at...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 26, 2025, for $2,491.38 to supply Tresiba FlexTouch 200 unit/mL 3mL insulin pens. This is a firm fixed-price delivery order with an ultimate completion date of September 29, 2025, and represents a non-set-aside competitive award. The order will be fulfilled at AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters. This delivery order is...
- The Defense Logistics Agency awarded a delivery order valued at approximately $74,717 to AmerisourceBergen Drug Corp for the supply of Tresiba FlexTouch 200 unit/mL 3mL insulin pens. The contract, awarded on August 7, 2025, with an ultimate completion date of August 8, 2025, utilizes a firm fixed price structure and carries no set-aside designation. Performance will be executed from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order falls under...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order on July 17, 2025, by the Defense Logistics Agency for the supply of Tresiba FlexTouch 200 unit/mL 3mL insulin pens, with a ceiling value of $3,126.29. This is a firm fixed price, non-set-aside contract with a completion date of July 18, 2025, and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop...
- The Defense Logistics Agency awarded a $2,491.38 delivery order to AmerisourceBergen Drug Corp for Tresiba FlexTouch 200 Unit/mL 3mL insulin pens on May 6, 2025, with completion scheduled for May 7, 2025. This competitively awarded, firm fixed-price contract represents a small-value pharmaceutical procurement with no set-aside designation. The product will be delivered to the Place of Performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This...
- The Defense Logistics Agency awarded a $1,211.75 delivery order to AmerisourceBergen Drug Corp for Tresiba FlexTouch 200 Unit/ML 3ML insulin pens. This firm fixed price, non-competitive delivery order was issued on September 26, 2025, with an ultimate completion date of September 29, 2025. The order was fulfilled at the vendor's Conshohocken, Pennsylvania location, where AmerisourceBergen maintains its corporate headquarters as a major pharmaceutical distributor serving federal medical...
- SPE2DB22D1002Indefinite Delivery Contract
- SPE2DB22D1002-SPE2DB25FLEV0Delivery Order
The Defense Logistics Agency awarded a $1,424.71 firm fixed-price delivery order to AmerisourceBergen Drug Corp on July 11, 2025, for the supply of Tresiba FlexTouch 200 Unit/mL 3mL insulin pens. This is a non-set-aside competitive award with an ultimate completion date of July 14, 2025, and performance to be fulfilled at the contractor's facility in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical, designated SPE2DX, valued at $999,999,999.00 through December 2026. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that serves as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. As a prime contractor on the DLA's comprehensive pharmaceutical supply contract, the company provides a wide range of medications and medical supplies across multiple therapeutic domains to the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. This award for Tresiba insulin pens reflects the company's ongoing role as a preferred supplier for diabetes management medications within the federal military medical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.4k | 7/11/25 |